Aim To examine the impact of diabetes mellitus on procedural outcomes of patients who underwent percutaneous coronary intervention for chronic total occlusion.
Introduction
Diabetes mellitus is highly and increasingly prevalent among people with coronary artery disease, including those undergoing percutaneous coronary intervention (PCI) for chronic total occlusion [1, 2] . Diabetes has been associated with multivessel coronary artery disease, arterial calcification, high risk of peripheral artery disease and impaired left ventricular systolic function [3] . There are few studies investigating whether the presence of diabetes mellitus affects the procedural outcomes of chronic total occlusion PCI [3] [4] [5] [6] ; this was the focus of the present study.
Methods

Study participants
We examined the clinical and angiographic records of people who underwent PCI for chronic total occlusion between May 2012 and September 2015 by experienced operators at 11 centres in the USA (Table S1 ). Only the first procedure was included in the present analysis. Data collection was performed prospectively and retrospectively and recorded Correspondence to: Emmanouil S. Brilakis. E-mail: esbrilakis@gmail.com in a chronic total occlusion database (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention: PROGRESS CTO, Clinicaltrials.gov Identifier: NCT02061436) [1, [7] [8] [9] [10] [11] [12] [13] [14] . Some centres only enrolled participants during part of the study period because of the enrolment of the latter in other studies. The study was approved by the institutional review boards of each site. Study data were collected and managed using REDCap electronic data capture tools hosted at University of Texas Southwestern Medical Center [20] .
Definitions
Diabetes mellitus was defined as current intake of hypoglycaemic medications or elevated levels (>7.0 mmol/l) of fasting blood glucose on two separate occasions [4, 15] . Coronary chronic total occlusions were defined as coronary lesions with thrombolysis in myocardial infarction grade 0 flow of at least 3-month duration. Estimation of the occlusion duration was based on first onset of anginal symptoms, history of myocardial infarction in the target vessel territory, or comparison with a previous angiogram.
Technical success of PCI for chronic total occlusion was defined as successful chronic total occlusion revascularization with achievement of <30% residual diameter stenosis within the treated segment and restoration of thrombolysis in myocardial infarction grade 3 antegrade flow. Procedural success was defined as achievement of technical success with no in-hospital major adverse cardiac events (MACE). In-hospital MACE included any of the following adverse events prior to hospital discharge: death; myocardial infarction; recurrent symptoms requiring urgent repeat target vessel revascularization with PCI or coronary artery bypass graft surgery; tamponade requiring either pericardiocentesis or surgery; and stroke.
Statistical analysis
Continuous data were reported as mean AE SD (normally distributed data) or median and interquartile range (nonnormally distributed data) and compared using t-test or Wilcoxon rank-sum test, as appropriate. Categorical data were presented as frequencies or percentages and compared using chi-squared or Fisher's exact test, as appropriate. A two-sided P value of <0.05 was considered statistically significant. All statistical analyses were performed using JMP version 12.0 (SAS Institute, Cary, NC, USA).
Results
Clinical and angiographic characteristics
During the study period, 1308 participants underwent 1333 chronic total occlusion PCI procedures at the study sites, but only the first chronic total occlusion intervention was included. The mean AE SD participant age was 65.5 AE 10.2 years, 84.2% of the participants were men, 41% had a history of myocardial infarction, 65% had previously undergone PCI, 34% had previously undergone coronary artery bypass graft surgery and 45% had diabetes mellitus ( Table 1) . As compared with participants without diabetes, participants with diabetes had a higher prevalence of hypertension, dyslipidaemia and previous coronary artery bypass graft surgery, but overall chronic total occlusion lesion complexity was similar in the two groups. The prevalence of moderate/severe calcification (61 vs 56%; P = 0.12), and proximal cap ambiguity (33 vs 30%; P = 0.27) was similar among participants with and without diabetes.
Procedural outcomes and complications
Technical (90.7 vs 90.3%; P = 0.8) and procedural (89.3 vs 89.1%; P = 0.9) success was similar in participants with and without diabetes mellitus ( Table 1) . The final successful crossing strategy was also similar between the two groups (retrograde: 30 vs 27.7%; antegrade wire escalation: 45.8 vs 47.2%; antegrade dissection and re-entry: 24 vs 25%; P = 0.66). The duration of the procedure and fluoroscopy time were similar in both groups; however, the radiation dose was higher in participants with diabetes, whereas contrast volume was lower. MACE occurred in 30 of 1308 (2.4%) participants, with similar frequency in those with and without diabetes mellitus: death (0.4 vs 0.3%; P = 0.51), myocardial infarction (1.3 vs 0.5%; P = 0.11), stroke (0.4 vs 0.1%; P = 0.4), emergency PCI (0.3 vs 0.3%; P = 0.82), emergency coronary artery bypass graft surgery (none) and emergency pericardiocentesis (0.6 vs 0.6%; P = 0.99).
Discussion
The main findings of the present study were (1) that diabetes was highly prevalent among people undergoing PCI for chronic total occlusion and (2) that similar success and What's new?
• Chronic total occlusions are a common and complex type of coronary artery disease that can be challenging to treat with percutaneous coronary intervention (PCI). We examined a large, multicentre registry of PCI for chronic total occlusion to determine the impact of diabetes mellitus on outcomes. Diabetes was highly prevalent (44.6%).
• Although diabetes was associated with more complex clinical and angiographic characteristics, it did not influence procedural success and complications, suggesting that the presence of diabetes is not a contraindication to PCI for chronic total occlusion.
ª 2016 Diabetes UK complication rates were found in people with diabetes as compared with people without diabetes. Nearly one in two participants who underwent PCI for chronic total occlusion in the present study (44.6%) had diabetes mellitus, attesting to its important role in the development of coronary atherosclerosis. The high prevalence of diabetes is probably, at least in part, associated with the high prevalence of obesity (the mean BMI was 30. 4 among 281 people who underwent retrograde PCI for chronic total occlusion in Japan [16] , 43.3% among 498 people who were enrolled in the Japan chronic total occlusion registry [17] , and 29% among 1395 people in the European Registry of chronic total occlusions (ERCTO) [18] . In contrast to some previous studies, the present study did not find any significant difference in procedural techniques and outcomes of PCI for chronic total occlusion between people with and without diabetes mellitus. The results showed high technical and procedural success and low MACE rates, probably related to inclusion of high-volume centres and experienced operators. Sohrabi et al. [5] reported a higher incidence of in-hospital adverse events among people with diabetes, with higher rates of repeat revascularization (20.6 vs 7%; P = 0.04), bleeding (2.9 vs 0.8%), cardiac death (2.9 vs 0%) and myocardial infarction (2.9 vs 0.8%); however, long-term outcomes were not affected. Galassi et al. [18] showed a 27.5% prevalence of diabetes in successful PCI procedures for chronic total occlusion and 33.7% in unsuccessful procedures (P = 0.04). Similarly to the present study, Ruiz-Garcia et al. [3] reported similar favourable clinical and angiographic outcomes in people with and without diabetes. Achievement of similar success rates in spite of slightly worse angiographic characteristics among people with diabetes (Table 1 ) could, at least in part, be explained by application of the hybrid approach to chronic total occlusion crossing that advocates systematic assessment of the angiogram and early change if the initially selected strategy is unsuccessful [19] .
The present study has limitations; it was observational and only reported procedural outcomes without long-term follow-up, which might be worse among people with diabetes because of higher risk of in-stent restenosis [5] . There was no clinical event adjudication by a clinical events committee. Multiple comparisons were performed on the characteristics of the two study groups increasing the likelihood of finding a spurious association. All procedures were performed at centres experienced in chronic total occlusion contemporary crossing techniques and strategies [19] . The results of the present study may therefore not be generalizable to settings with limited experience in PCI for chronic total occlusion. In summary, PCI was performed for chronic total occlusion in people with and without diabetes mellitus with equally high success and equally low complication rates.
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